Drug Shortage Report for FULVESTRANT INJECTION
| Report ID | 126796 |
| Drug Identification Number | 02468549 |
| Brand name | FULVESTRANT INJECTION |
| Common or Proper name | FULVESTRANT INJECTION |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | FULVESTRANT |
| Strength(s) | 50MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 5ml |
| ATC code | L02BA |
| ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-01-06 |
| Actual start date | |
| Estimated end date | 2021-01-12 |
| Actual end date | 2020-11-09 |
| Shortage status | Avoided shortage |
| Updated date | 2020-11-10 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-11-10 | French | Compare |
| v5 | 2020-11-10 | English | Compare |
| v4 | 2020-11-03 | French | Compare |
| v3 | 2020-11-03 | English | Compare |
| v2 | 2020-10-21 | French | Compare |
| v1 | 2020-10-21 | English | Compare |
Showing 1 to 6 of 6